NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

No news today and nothing has changed this week except the price.

We can assume the L trial still hasn't reached full enrollment since it hasn't been announced. The L trial continues to be delayed by the screening halt that is still in effect per the PR today. LP stated multiple times at the annual meeting that the screening hold has delayed the trial which completely dismantles the theory that it was planned or that enough patients to finish enrollment were in the pipeline.

The Direct phase 2 still hasn't started. It is doubtful the plans have even been approved by the FDA and it is possible they haven't even been submitted for review yet.

The share price fell another 27% this week due to management's silence about the partial clinical hold and the lack of any news as well as the total uncertainty of the status of NWBO's only two pipeline products.

The diehards continue to spin positive yarns as the share prices rapidly moves closer to penny stock status. Yep, nothing new to report this week. Hope everyone has a great weekend.

Pop quiz for those who will be reading the board this weekend. What will the terms of the next toxic financing look like if we extrapolate the discount necessary for the last one at the current price of $2.30? Using the discounted price calculated from step 1. how much dilution (# of shares and warrants) will be issued to raise 42m this quarter. The 42m is based on the funds necessary for operations last quarter. Hint: be sure to include the rebalancing and additional shares/warrants required for Cognate with all financings under $4. GL